Informing the Product Development of an mHealth Solution for People with Multiple Sclerosis Through Early Health Technology Assessment

Guido Giunti*, Jari Haverinen, Jarmo Reponen

*Corresponding author for this work

Research output: Chapter in Book/Conference proceedings/Edited volumeConference contributionScientificpeer-review

2 Citations (Scopus)
24 Downloads (Pure)

Abstract

The potential of mHealth is enormous for chronic conditions, yet the integration of these technologies into the clinical infrastructures and healthcare pathways remains an ongoing challenge. Digi-HTA has been developed to support health technology assessment activities for novel digital healthcare technologies. The use of Early Health Technology Assessment (EHTA) can help product development. The present study describes the way in which EHTA can guide the development of a product to anticipate future needs and market access.

Original languageEnglish
Title of host publicationMEDINFO 2021
Subtitle of host publicationOne World, One Health - Global Partnership for Digital Innovation - Proceedings of the 18th World Congress on Medical and Health Informatics
EditorsPaula Otero, Philip Scott, Susan Z. Martin, Elaine Huesing
PublisherIOS Press
Pages1042-1043
Number of pages2
ISBN (Electronic)9781643682648
DOIs
Publication statusPublished - 2022
Event18th World Congress on Medical and Health Informatics: One World, One Health - Global Partnership for Digital Innovation, MEDINFO 2021 - Virtual, Online
Duration: 2 Oct 20214 Oct 2021

Publication series

NameStudies in Health Technology and Informatics
Volume290
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Conference

Conference18th World Congress on Medical and Health Informatics: One World, One Health - Global Partnership for Digital Innovation, MEDINFO 2021
CityVirtual, Online
Period2/10/214/10/21

Keywords

  • Chronic Disease
  • Health Technology Assessment
  • Telemedicine

Fingerprint

Dive into the research topics of 'Informing the Product Development of an mHealth Solution for People with Multiple Sclerosis Through Early Health Technology Assessment'. Together they form a unique fingerprint.

Cite this